Public procurement notice: Contract Notice
Published: 2019-03-15
Buyer: The NHS Commissioning Board (Operating Under the Name of NHS England)
Country: UK
Contract type: Supplies
Procedure: Open procedure
CPV classification: 33600000: Pharmaceutical products
Estimated value: 498773842 GBP
Submission deadline: 2019-04-15
Award criteria: The most economic tender

Technical requirements: NHS Framework for the NHS South of England, Branded Medicines – Tranche A, Cytokine Modulators and other monoclonal Antibodies, and Antiretrovirals for Midlands and East and North of England
CM/PHR/16/5521/01 - NHS Framework for the NHS South of England, Branded Medicines – Tranche A, Period of framework: 1.9.2019 to 31.8.2021 with an option to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months
CM/PHR/16/5521/02 - NHS Framework for the NHS South of England, Branded Medicines – Annual Tranche - Cytokine Modulators and other monoclonal antibodies, Period of framework: 1.9.2019 to 31.8.2020 with an option to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months.
CM/PHR/16/5521/03 - NHS Framework Agreement for Proprietary Pharmaceuticals Interim 2019 – Midlands and East and North of England, Period of framework agreement: Midlands and East 1.9.2019 to 29.2.2020: North of England 1.9.2019 to 28.2.2021.
CM/PHR/16/5521/01 - NHS Framework for the NHS South of England, Branded Medicines – Tranche A, Period of framework: 1.9.2019 to 31.8.2021 with an option to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.
CM/PHR/16/5521/02 - NHS Framework for the NHS South of England, Branded Medicines – Annual Tranche - Cytokine Modulators and other monoclonal antibodies
CM/PHR/16/5521/02 - NHS Framework for the NHS South of England, Branded Medicines – Annual Tranche - Cytokine Modulators and other monoclonal antibodies, Period of framework: 1.9.2019 to 31.8.2020 with an option to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months.
CM/PHR/16/5521/03 - NHS Framework Agreement for Proprietary Pharmaceuticals Interim 2019 - Midlands and East and North of England
CM/PHR/16/5521/03 - NHS Framework Agreement for Proprietary Pharmaceuticals Interim 2019 - Midlands and East and North of England, Period of framework agreement: Midlands and East 1.9.2019 to 29.2.2020: North of England 1.9.2019 to 28.2.2021.
This procurement exercise will be conducted on the eTendering portal at www.cmu.bravosolution.co.uk. Candidates wishing to be considered for this procurement exercise must register, and provide additional procurement specific information (if requested), through the eTendering portal as follows:
1.1) If not already registered, Candidates should register on the eTendering portal at https://www.cmu.bravosolution.co.uk and click the link to register:
(f) Once you have expressed interest, the ITT will move to “My ITTs”, where you can download additional documentation (if required), and construct your reply as instructed. You must then publish your reply using the “Publish” button.
1.3) For any support in registering on the portal or submitting your expression of interest please contact the eTendering Help-desk at +44 800 368 4850 or help@bravosolution.co.uk.
To manage and assess supplier information the Contracting Authority requests candidates provide their company profile in the Government's Supplier Registration Service (which has replaced sid4gov), as follows:
2.1) If not already registered (the previous sid4gov password, login and details will still be on the system), candidates must go to the following web page https://supplierregistration.cabinetoffice.gov.uk and select “Register” at the top of the page. Key in details as requested to search for your company. If you do not have a D-U-N-S® Number, click on the link at the right of the page to obtain a number from D&B. Candidates must obtain a Dun & Bradstreet (D&B) D-U-N-S® Number to enable registration on the system.


Award value: 498773842